Literature DB >> 3244648

Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary culture.

J B van Bree1, K L Audus, R T Borchardt.   

Abstract

The mechanism of transport of baclofen, a centrally acting muscle relaxant, across the blood-brain barrier (BBB) was studied using an in vitro model. The model consisted of a monolayer of bovine brain endothelial cells grown in primary culture on a porous regenerated cellulose membrane. The transport of baclofen across the monolayer expressed time and concentration dependency and was saturable. Transport data were corrected for diffusion and fitted to the Michaelis-Menten Vmax model: Km = 58.5 microM, Vmax = 0.23 nmol/min. The results validate the use of the in vitro BBB model as described and support the hypothesis that baclofen penetrates the BBB by means of a carrier-mediated transport system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244648     DOI: 10.1023/a:1015959628008

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Kinetic analysis of blood-brain barrier transport of amino acids.

Authors:  W M Pardridge; W H Oldendorf
Journal:  Biochim Biophys Acta       Date:  1975-08-05

2.  Isolated microvessels: the blood-brain barrier in vitro.

Authors:  J T Hjelle; J Baird-Lambert; G Cardinale; S Specor; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Lipid solubility and drug penetration of the blood brain barrier.

Authors:  W H Oldendorf
Journal:  Proc Soc Exp Biol Med       Date:  1974-12

4.  [3H](-)Baclofen: an improved ligand for GABAB sites.

Authors:  N G Bowery; D R Hill; A L Hudson
Journal:  Neuropharmacology       Date:  1985-03       Impact factor: 5.250

5.  Characteristics of the large neutral amino acid transport system of bovine brain microvessel endothelial cell monolayers.

Authors:  K L Audus; R T Borchardt
Journal:  J Neurochem       Date:  1986-08       Impact factor: 5.372

Review 6.  Neutral amino acid transport at the human blood-brain barrier.

Authors:  W M Pardridge; T B Choi
Journal:  Fed Proc       Date:  1986-06

7.  Catecholamine-metabolizing enzymes of bovine brain microvessel endothelial cell monolayers.

Authors:  A Baranczyk-Kuzma; K L Audus; R T Borchardt
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

8.  Serotonin, norepinephrine, and histamine mediation of endothelial cell barrier function in vitro.

Authors:  D Bottaro; D Shepro; S Peterson; H B Hechtman
Journal:  J Cell Physiol       Date:  1986-08       Impact factor: 6.384

9.  Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism.

Authors:  K L Audus; R T Borchardt
Journal:  Pharm Res       Date:  1986-04       Impact factor: 4.200

  9 in total
  18 in total

Review 1.  Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport.

Authors:  J B Van Bree; A G De Boer; M Danhof; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1992-12-11

2.  Permeation and systemic absorption of R- and S-baclofen across the nasal mucosa.

Authors:  Hefei Zhang; Mark Schmidt; Daryl J Murry; Maureen D Donovan
Journal:  J Pharm Sci       Date:  2011-01-31       Impact factor: 3.534

Review 3.  The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.

Authors:  K L Audus; R L Bartel; I J Hidalgo; R T Borchardt
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

4.  Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis.

Authors:  Y Deguchi; K Inabe; K Tomiyasu; K Nozawa; S Yamada; R Kimura
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

5.  The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system.

Authors:  J B van Bree; A V Baljet; A van Geyt; A G de Boer; M Danhof; D D Breimer
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

6.  Stereoselective transport of baclofen across the blood-brain barrier in rats as determined by the unit impulse response methodology.

Authors:  J B van Bree; C D Heijligers-Feijen; A G de Boer; M Danhof; D D Breimer
Journal:  Pharm Res       Date:  1991-02       Impact factor: 4.200

7.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

8.  Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.

Authors:  I Knerr; P L Pearl; T Bottiglieri; O Carter Snead; C Jakobs; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

9.  Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.

Authors:  T Terasaki; S Takakuwa; A Saheki; S Moritani; T Shimura; S Tabata; A Tsuji
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

Review 10.  In vitro, in vivo and in silico models of drug distribution into the brain.

Authors:  Scott G Summerfield; Kelly C Dong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-13       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.